Structures by: Legendre A. O.
Total: 10
Ticlopidine hydrochloride form II
C14H15Cl2NS
CrystEngComm (2011) 13, 19 5737
a=5.4410(2)Å b=12.2260(4)Å c=21.7050(7)Å
α=90° β=101.040(2)° γ=90°
Doxycycline monohydrate
C22H24N2O8,H2O
CrystEngComm (2012) 14, 7 2532
a=5.9241(1)Å b=9.4808(2)Å c=18.5568(4)Å
α=90.00° β=91.192(2)° γ=90.00°
P-nitrobenzylidene-p-phenylaminoaniline
C19H15N3O2
Acta crystallographica Section B, Structural science, crystal engineering and materials (2015) 71, Pt 4 416-426
a=10.3885(3)Å b=16.7902(4)Å c=8.9064(2)Å
α=90° β=97.704(2)° γ=90°
2,4-dinitrobenzylidene-p-phenylaminoaniline
C19H14N4O4
Acta crystallographica Section B, Structural science, crystal engineering and materials (2015) 71, Pt 4 416-426
a=6.5715(2)Å b=15.0533(4)Å c=17.0598(5)Å
α=90° β=90° γ=90°
P-nitrobenzylidene-p-diethylaminoaniline
C17H19N3O2
Acta crystallographica Section B, Structural science, crystal engineering and materials (2015) 71, Pt 4 416-426
a=16.1019(5)Å b=7.6028(3)Å c=12.3616(4)Å
α=90° β=91.615(3)° γ=90°
Terebic acid
C7H10O4
Acta Crystallographica Section C (2012) 68, 8 o294-o297
a=5.9890(10)Å b=5.6630(10)Å c=22.2820(10)Å
α=90.00° β=97.070(10)° γ=90.00°
Doxycycline chloride salt dihydrate
C22H25N2O81,2(H2O1),Cl11)
Crystal Growth & Design (2014) 14, 8 3711
a=11.0979(1)Å b=12.7557(1)Å c=16.8829(2)Å
α=90° β=90° γ=90°
Doxycycline acetic acid dihydrate
C22H24N2O8,2(O1H2),1(C2O2H4)
Crystal Growth & Design (2014) 14, 8 3711
a=6.4753(2)Å b=9.0970(4)Å c=42.8077(16)Å
α=90° β=90° γ=90°
Didanosine
C10H12N4O3,0.125H2O
Crystal Growth & Design (2010) 10, 4 1885
a=7.277(1)Å b=10.052(2)Å c=14.476(3)Å
α=90.000° β=93.71(1)° γ=90.000°
Doxycycline nitrate salt hemihydrate
2(C22H25N2O8)1,2(N1O3)1,1(O1H2)
Crystal Growth & Design (2014) 14, 8 3711
a=8.0679(2)Å b=8.9156(3)Å c=16.6791(5)Å
α=77.872(2)° β=87.581(2)° γ=74.133(3)°